KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Cash & Current Investments (2018 - 2025)

Aurinia Pharmaceuticals' Cash & Current Investments history spans 7 years, with the latest figure at $398.0 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 11.02% year-over-year to $398.0 million; the TTM value through Dec 2025 reached $398.0 million, up 11.02%, while the annual FY2025 figure was $398.0 million, 11.02% up from the prior year.
  • Cash & Current Investments reached $398.0 million in Q4 2025 per AUPH's latest filing, up from $351.8 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $466.1 million in Q4 2021 to a low of $286.4 million in Q3 2021.
  • Average Cash & Current Investments over 5 years is $356.6 million, with a median of $350.6 million recorded in 2023.
  • The largest YoY upside for Cash & Current Investments was 31.51% in 2022 against a maximum downside of 16.45% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $466.1 million in 2021, then dropped by 16.45% to $389.4 million in 2022, then dropped by 9.99% to $350.5 million in 2023, then increased by 2.28% to $358.5 million in 2024, then increased by 11.02% to $398.0 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Cash & Current Investments are $398.0 million (Q4 2025), $351.8 million (Q3 2025), and $315.1 million (Q2 2025).